Solifenacin

Solifenacin: The Bladder Medicine with Better Tolerability

Solifenacin is an anticholinergic for overactive bladder that targets the bladder receptors more strongly than older substances in its group. It works about as well, but is usually better tolerated and only needs to be taken once a day. Two points are especially typical of solifenacin: the possible prolongation of the QT interval of the heart, and its breakdown via the enzyme CYP3A4, which is inhibited by grapefruit and certain medicines.

See more detail

Solifenacin once a day — without gaps

Reminders, tolerability and interactions in one place — free in the brite app.

Track solifenacin

1. At a Glance: Technical Data Sheet

PropertyDetails
Active ingredientSolifenacin (usually as solifenacin succinate)
ATC codeG04BD08
Drug classAnticholinergic (muscarinic receptor antagonist) with a preference for M3 receptors
Dosage formsFilm-coated tablets, usually 5 mg and 10 mg; also as an oral suspension
Half-lifeLong, in the order of 45 to 70 hours — the basis for once-daily dosing
Maximum daily doseAccording to the SmPC, usually 10 mg daily; lower with impaired kidney or liver function
Onset of effectFirst effects after about a week, assessment after about 4 to 12 weeks
Prescription statusPrescription-only medicine
Notable featureMore bladder-selective than older anticholinergics; broken down via CYP3A4, possible QT prolongation
Table scrolls to the right

2. How it works: what bladder selectivity means

Anticholinergics block muscarinic receptors — the docking sites for the messenger substance acetylcholine. As a result, the bladder muscle contracts involuntarily less often, and the bladder holds more before the urge to urinate sets in. So far, that applies to every substance in this group.¹

The difference lies in the detail. Muscarinic receptors come in several subtypes. Bladder contraction is driven mainly by the M3 type; in the salivary glands, the eye, the heart and the brain, other subtypes and other tissue properties play a major role. Solifenacin binds preferentially to M3 receptors and also reaches the brain less readily than smaller, more fat-soluble substances. That is exactly what explains its milder profile.

Selective does not mean exclusive. “Bladder-selective” is a question of proportion, not an on-off switch. Even on solifenacin, dry mouth and constipation are the most common side effects — they simply occur less often and less severely than with older substances such as oxybutynin. The better tolerability is a genuine advantage, but not a free pass.

Solifenacin is used for overactive bladder (also known as irritable bladder) with a sudden, compelling urge to urinate, frequent trips to the toilet and, where applicable, urge incontinence — that is, involuntary leakage of urine at the moment of urgency. It treats the symptoms: it dampens the complaints for as long as it is taken and does not cure the cause.


3. Dosing and taking it: once a day

The following information describes the usual approach according to the SmPC (Summary of Product Characteristics). It is not a dosing instruction — your dose is set by the treating practice.

  • Once a day: the long half-life allows a single dose per day. That is more than convenience — the simpler a regimen, the less often a dose is forgotten, and the more honestly the effect can be judged.
  • Usually a low start: treatment normally begins with the lower strength; only if the effect is insufficient and the tolerability is good is the dose increased.
  • Independent of meals: according to current knowledge, food does not affect absorption to any relevant degree. The tablet is swallowed whole with water.
  • A fixed time: a consistent time of day keeps the blood level stable and makes forgetting less likely. The basics are covered in the guide how to take medications correctly.
  • Missed dose: if you notice on the same day, it is usually taken late; otherwise you carry on at the next regular time. A double dose is not the answer — see missed a medication.
The long half-life cuts both ways. It forgives a forgotten tablet more easily than short-acting preparations do. At the same time, the level builds up and falls only slowly: after starting, it takes a few days to reach a steady state, and a side effect does not vanish overnight after stopping. So judge the effect over weeks, not days — ideally with a bladder diary (a record of when and how much you pass urine) that you take along to your doctor's appointment.

One tablet a day — but really every day

brite takes care of the reminder, and you can see the history at your next appointment.

Set up a reminder

4. Side effects: milder, but not harmless

The side-effect profile follows the same pattern as with all anticholinergics — only in a milder form. Two complaints clearly top the list.

  • Dry mouth: the most common side effect. It is dose-dependent — on the higher strength it occurs noticeably more often. Small sips throughout the day, sugar-free chewing gum and consistent dental care soften it.
  • Constipation: the second most common. It is often underestimated because it develops slowly. Fibre, exercise and enough fluids belong in the picture from the start, not only after weeks.
  • Blurred vision and dry eyes: less common than with older substances, but possible.
  • Nausea, abdominal discomfort, heartburn: occasional, usually in the early phase.
  • Residual urine, up to urinary retention: rare, but relevant — especially with a pre-existing bladder-emptying disorder.
  • Tiredness and drowsiness: much less common than with anticholinergics that readily enter the brain.
What should not be sat out. Being unable to pass urine with pressure in the lower abdomen, sudden eye pain with worsening vision (a suspected acute glaucoma attack in angle-closure glaucoma), a persistent absence of bowel movements with abdominal pain and vomiting, or swelling of the face and tongue: these are reasons to seek medical help immediately rather than waiting for your next appointment. How to document and report side effects is explained under side effects of medications.

Like all anticholinergics, solifenacin is not suitable in untreated angle-closure glaucoma, urinary retention, severe gastrointestinal disease with obstruction of the bowel, or myasthenia gravis. These diagnoses need to be on the table before treatment starts.


5. QT prolongation: what sets this substance apart

The QT interval is a section of the ECG. It describes how long the heart's ventricles need to recover electrically after each beat. If this phase becomes too long, a dangerous heart rhythm disorder can develop in rare cases — known as torsade de pointes.¹

Solifenacin can prolong the QT interval in a dose-dependent way. For most people with a healthy heart, this has no practical significance. It becomes critical when several factors come together — and that is precisely the point this article wants to highlight: the risk almost never comes from solifenacin alone, but from combinations.

When the QT interval really becomes an issue. Caution is needed with known long QT syndrome, previous heart rhythm disorders, low potassium or magnesium levels, a markedly slow pulse — and above all when other QT-prolonging medicines are taken at the same time. These include certain antidepressants such as citalopram, some antipsychotics, some antiarrhythmics and macrolide antibiotics such as clarithromycin. If you have sudden dizziness with loss of consciousness, attacks of a racing heart or a collapse, call 112 (emergency number in Germany) immediately.

In practice, this does not mean these combinations are forbidden. It means they have to be known. If you are prescribed solifenacin, you should disclose your complete medication list — including preparations prescribed by another practice. Depending on the situation, an ECG is recorded, potassium and magnesium levels are checked (understanding blood values) or one of the two substances is swapped.

There is, incidentally, no warning sign you can feel: a prolonged QT interval does not hurt. What may stand out are heart palpitations, a sudden dizzy spell or a brief loss of consciousness — events like these always need to be investigated and should not be put down to “circulation”.

6. CYP3A4: grapefruit and strong inhibitors

In the liver, solifenacin is broken down mainly by the enzyme CYP3A4. This enzyme is one of the body's most important breakdown routes — and it can be blocked. If it is inhibited, the drug builds up: the blood level rises, and with it dry mouth, constipation and the risk of QT prolongation.

Grapefruit is not a myth. Grapefruit and grapefruit juice inhibit CYP3A4 in the gut wall — for hours to days, not just at the moment you drink it. Leaving a gap before or after the tablet therefore does little. Pomelo and bitter orange (Seville orange, often found in marmalade) act in the same way. What this means in general is explained in the guide grapefruit and medications. Ordinary oranges, mandarins and lemons are not affected.

On the medication side, it is mainly strong CYP3A4 inhibitors: certain antifungals used against fungal infections, macrolide antibiotics such as clarithromycin, and some HIV medicines. When they are used at the same time, the solifenacin dose is usually capped or treatment is temporarily adjusted. The reverse case also exists: strong CYP3A4 inducers such as St John's wort or certain antiepileptics speed up the breakdown and can weaken the effect.

The tricky part is the everyday situation. An antibiotic for sinusitis is prescribed for seven days — by a different practice that knows nothing about the bladder tablet. Short in-between prescriptions like this are the typical trigger. A complete, up-to-date medication plan that you show everywhere prevents this more reliably than any amount of studying package leaflets.


7. Interactions at a glance

CombinationConsequenceWhat to do
Strong CYP3A4 inhibitors (antifungals, clarithromycin, certain HIV medicines)Solifenacin level rises, more side effectsClarify a dose cap or an alternative with your doctor
Grapefruit, pomelo, bitter orangeThe same effect via the gut wallAvoid during treatment
QT-prolonging medicines, e.g. citalopramAdditive QT prolongationCheck the combination specifically, ECG if needed
Other medicines with anticholinergic effectsCumulative dry mouth, constipation, confusionHave the total burden assessed by a doctor
Water tablets (diuretics), laxatives with potassium lossLow potassium increases the QT riskMonitor potassium and magnesium
Metoclopramide and other agents that stimulate gut motilityOpposing effects, both become weakerQuestion the purpose of the combination
AlcoholIncreased tiredness; alcohol also irritates the bladderHold back, see medications and alcohol
Table scrolls to the right

The practical rule is simple: every new prescription and every over-the-counter product should be checked against your existing list before it is added — that is what the interaction check is for.


8. Kidney and liver function limit the dose

Solifenacin is partly broken down by the liver and partly excreted by the kidneys. Both organs therefore set a limit on the dose — and for this substance that limit is laid down more specifically than for some others.

  • Impaired kidney function: with markedly reduced filtration capacity, the SmPC caps the daily dose. In chronic kidney disease, the current eGFR value therefore belongs in the prescribing decision.
  • Impaired liver function: with moderate impairment, the dose is also capped; with severe liver impairment, solifenacin is not suitable.
  • Combined with a CYP3A4 inhibitor, the limits apply all the more — the effects add up.
  • Dialysis: here solifenacin is usually not indicated.

What matters is that kidney function is not a fixed value. It changes with age, dehydration, feverish infections and new medicines. A dose that suited you two years ago can be too high today. What applies in general is set out in the guide medications for kidney and liver disease.


9. In older age: better tolerated, but the total burden counts

Solifenacin is considered the better-tolerated choice among the anticholinergics — it reaches the brain less readily than older, highly fat-soluble substances and triggers confusion less often. That is a real advantage, especially compared with oxybutynin. But it is no reason to tick the subject off.

Because the decisive factor in older age is not the individual preparation but the total anticholinergic burden: the sum of all the medicines that have even a weak anticholinergic effect. Older antidepressants, some antipsychotics, older antihistamines, certain stomach and bladder medicines — each unremarkable on its own, but together enough to impair memory, attention and steadiness on your feet.

The right question in the consulting room. It is not “Is solifenacin dangerous?” but: “How many of my medicines have an anticholinergic effect — and is the total still acceptable?” If you take several preparations, the guides medications in old age and polypharmacy give you the framework for this. If cognitive changes appear, the beta-3 agonist mirabegron is an alternative with no anticholinergic effect.

On top of that, in older age there is the second point from section 5: older people more often take medicines that affect the QT interval and more often have low potassium levels caused by water tablets. Together, these make checking combinations more important than in younger patients.


10. What you can realistically expect

Honesty pays off here, because unrealistic expectations are the most common reason for disappointment and for stopping treatment.

In overactive bladder, anticholinergics on average reduce the number of trips to the toilet and of urgency episodes, and they reduce the number of incontinence episodes. Very few people become completely free of symptoms. The effect is real and noticeable in everyday life for many — but it is gradual: “I never make it in time” becomes “I usually make it”, not “I don't notice anything any more”.²,³

The difference becomes visible when you measure it. Keep a bladder diary for three days before starting treatment and again after six to eight weeks: the time and amount each time you pass urine, how much you drink, urgency episodes, involuntary leakage of urine. Without this comparison, real progress is regularly overlooked — with it, your practice also has a basis for the next decision. Fluid intake, toilet visits and doses can be kept side by side in a digital health history.

And the second part of the truth: the medicine is only half the treatment. Bladder training, regulated drinking habits and pelvic floor training come first in overactive bladder and work better together with the medicine than either does on its own.³ Fixed toilet times instead of going whenever the urge strikes, slowly lengthened intervals, waiting for urge waves to pass while standing still instead of rushing off — these are the building blocks that turn a moderate drug effect into a noticeable gain in everyday life. Urinary incontinence is a medical problem like any other and no reason to avoid the subject.⁴


11. Solifenacin experiences: what patients really ask

“On my previous medicine I had an extremely dry mouth. Will it be better now?”

In many cases, yes. Solifenacin binds preferentially to the receptors of the bladder muscle and therefore causes, on average, less frequent and milder dry mouth than older anticholinergics. That does not make it disappear — it remains the most common side effect, and it increases at the higher dose step. If the lower strength works well enough, it is therefore often the better choice. Tell your practice specifically how much the dryness bothers you: therapeutically, there is a big difference between “annoying when I talk” and “it wakes me up at night”.

“I read that this medicine can affect the heart. Should I be worried?”

This refers to the possible prolongation of the QT interval. For people with a healthy heart, normal potassium and magnesium levels and no other QT-prolonging medicines, it is usually not a practical problem. It becomes relevant with combinations — for instance with certain antidepressants, antipsychotics or macrolide antibiotics — and with known heart rhythm disorders. The right response is therefore not worry but transparency: show your complete medication list, mention any existing heart conditions and, if you faint or have attacks of a racing heart, get medical help immediately.

“Can I still have my grapefruit juice in the morning?”

Better not while you are being treated with solifenacin. Grapefruit inhibits the enzyme that breaks down the drug, and it does so persistently — leaving a gap before or after the tablet does not solve the problem. The level can rise as a result, which intensifies dry mouth, constipation and the QT risk. Pomelo and bitter orange are affected too. Other citrus fruits such as oranges, mandarins and lemons, on the other hand, you can eat and drink as normal.

New antibiotic prescribed? Check it first.

The interaction check recognises CYP3A4 inhibitors and QT combinations.

Check a combination

FAQ: Common questions about solifenacin

First effects usually appear within the first week, because the long half-life means the blood level has to build up first. The effect is usually assessed after four to twelve weeks. A bladder diary kept before starting and again after a few weeks makes the difference visible.
As a rule, yes. Solifenacin binds preferentially to the receptors of the bladder muscle and gets into the brain less readily, so dry mouth, constipation and confusion occur less often and less severely. On average, the efficacy is comparable. Which substance suits you is decided by the treating practice.
Grapefruit inhibits the enzyme CYP3A4, which breaks down solifenacin. This raises the level of the drug in the blood and makes side effects such as dry mouth, constipation and QT prolongation more likely. The inhibition lasts for hours to days, so leaving a gap does not help. Pomelo and bitter orange have a similar effect.
On the ECG, the QT interval describes how long the heart's ventricles need to recover electrically. If it is markedly prolonged, a dangerous rhythm disorder can rarely develop. You cannot feel a prolonged QT interval. It mainly becomes relevant with additional QT-prolonging medicines, low potassium or known heart rhythm disorders.
Yes. With markedly impaired kidney function and with moderate liver impairment, the SmPC caps the daily dose; with severe liver impairment, solifenacin is not suitable. Because kidney function changes with age, infections and new medicines, current values belong in the prescribing decision.
Usually not completely. What you can expect is a reduction in urgency episodes, trips to the toilet and incontinence episodes, not their disappearance. The benefit is real, but gradual. Combined with bladder training and regulated drinking habits, the result is clearly better than with the medicine alone.

Sources

  1. Summary of Product Characteristics (SmPC) for solifenacin succinate (current version, available through the German medicines information system). pharmnet-bund.de
  2. Gesundheitsinformation.de (IQWiG): Overactive bladder and urge incontinence — treatment options. Accessed 2026 — German source. gesundheitsinformation.de
  3. S2e guideline on urinary incontinence in geriatric patients — diagnosis and treatment (German Geriatrics Society, AWMF reg. no. 084-001) — German source. awmf.org
  4. gesund.bund.de: Urinary incontinence and overactive bladder. Accessed 2026 — German source. gesund.bund.de

Manage solifenacin safely in everyday life — with brite

Medication reminders, an interaction check and your bladder history in one place. Free.

Create medication plan
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Do not take solifenacin together with new medicines without having the combination checked — antibiotics, antifungals and antidepressants in particular can be relevant. If you faint, have attacks of a racing heart, sudden eye pain with worsening vision, or cannot pass urine and have lower abdominal pain, contact a doctor straight away or, in an emergency, call 112 (emergency number in Germany). The choice of medicine and the dose are always set individually by the treating practice. Last updated: September 2026.